George Bakris, MD, on the Renal Outcomes From the CREDENCE Trial


In this podcast, George Bakris, MD, from the University of Chicago, talks about the renal outcomes from the Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE) trial.

George Bakris, MD, is a professor of medicine and director of the American Heart Association's Comprehensive Hypertension Center at the University of Chicago Medicine in Chicago, Illinois.

Additional Resources: